These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 30606472)
1. Hypercholesterolaemia and coronary artery disease: A silent killer with several faces. Ferrières J Arch Cardiovasc Dis; 2019 Feb; 112(2):75-78. PubMed ID: 30606472 [No Abstract] [Full Text] [Related]
2. First insights from the EAS familial hypercholesterolaemia collaboration registry: FH is still underdiagnosed and undertreated. Stock J Atherosclerosis; 2019 Nov; 290():138-139. PubMed ID: 31610884 [No Abstract] [Full Text] [Related]
3. Dutch Lipid Clinic Network low-density lipoprotein cholesterol criteria are associated with long-term mortality in the general population. Séguro F; Bongard V; Bérard E; Taraszkiewicz D; Ruidavets JB; Ferrières J Arch Cardiovasc Dis; 2015 Oct; 108(10):511-8. PubMed ID: 26073227 [TBL] [Abstract][Full Text] [Related]
4. Familial hypercholesterolaemia: A guide for general practice. Brett T; Arnold-Reed D Aust J Gen Pract; 2019 Sep; 48(9):650-652. PubMed ID: 31476827 [No Abstract] [Full Text] [Related]
5. New data on familial hypercholesterolaemia and acute coronary syndromes: The promise of PCSK9 monoclonal antibodies in the light of recent clinical trials. Ellis KL; Pang J; Schultz CJ; Watts GF Eur J Prev Cardiol; 2017 Jul; 24(11):1200-1205. PubMed ID: 28482694 [TBL] [Abstract][Full Text] [Related]
6. Familial hypercholesterolaemia: clinical features and management. Pottle A Nurs Stand; 2005 Dec 14-2006 Jan 3; 20(14-16):55-65; quiz 66. PubMed ID: 16372559 [TBL] [Abstract][Full Text] [Related]
7. Complex disease management of pregnant young patient with familial hypercholesterolaemia complicated by coronary artery disease and cerebrovascular disease. Moss S; Tardo D; Doyle M; Rees D Cardiovasc Revasc Med; 2018 Dec; 19(8S):20-22. PubMed ID: 30017729 [TBL] [Abstract][Full Text] [Related]
8. A keen eye for risk. Ford TJ; Rocchiccioli P BMJ; 2018 Feb; 360():j5884. PubMed ID: 29419393 [No Abstract] [Full Text] [Related]
9. Homozygous familial hypercholesterolaemia: update on management. France M Paediatr Int Child Health; 2016 Nov; 36(4):243-247. PubMed ID: 27967828 [TBL] [Abstract][Full Text] [Related]
11. [PCSK9 - "missing link" in familial hypercholesterolemia : New therapeutic options in hypercholesterolemia and coronary artery disease]. Thiery J; Burkhardt R Herz; 2016 Jun; 41(4):281-9. PubMed ID: 27215417 [TBL] [Abstract][Full Text] [Related]
12. Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia. Rubba P; Gentile M; Marotta G; Iannuzzi A; Sodano M; De Simone B; Jossa F; Iannuzzo G; Giacobbe C; Di Taranto MD; Fortunato G Eur J Prev Cardiol; 2017 Jul; 24(10):1051-1059. PubMed ID: 28353356 [TBL] [Abstract][Full Text] [Related]
13. Treatment of severe hypercholesterolemia by LDL-apheresis: cholesterol-lowering effect and clinical evaluation. Saito Y; Shinomiya M; Shirai K; Yoshida S Beitr Infusionsther; 1988; 23():160-71. PubMed ID: 2484772 [No Abstract] [Full Text] [Related]
14. Recent advances in the understanding and care of familial hypercholesterolaemia: significance of the biology and therapeutic regulation of proprotein convertase subtilisin/kexin type 9. Page MM; Stefanutti C; Sniderman A; Watts GF Clin Sci (Lond); 2015 Jul; 129(1):63-79. PubMed ID: 25881720 [TBL] [Abstract][Full Text] [Related]
15. Long-term outcome in 53 patients with homozygous familial hypercholesterolaemia in a single centre in France. Bruckert E; Kalmykova O; Bittar R; Carreau V; Béliard S; Saheb S; Rosenbaum D; Bonnefont-Rousselot D; Thomas D; Emery C; Khoshnood B; Carrié A Atherosclerosis; 2017 Feb; 257():130-137. PubMed ID: 28131047 [TBL] [Abstract][Full Text] [Related]
16. Guidelines for the diagnosis and management of familial hypercholesterolaemia. Sullivan D; Heart Lung Circ; 2007 Feb; 16(1):25-7. PubMed ID: 17188936 [No Abstract] [Full Text] [Related]
17. Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial. Stein EA; Gipe D; Bergeron J; Gaudet D; Weiss R; Dufour R; Wu R; Pordy R Lancet; 2012 Jul; 380(9836):29-36. PubMed ID: 22633824 [TBL] [Abstract][Full Text] [Related]
18. Managing homozygous familial hypercholesterolaemia from cradle to grave. Thompson GR Atheroscler Suppl; 2015 May; 18():16-20. PubMed ID: 25936299 [TBL] [Abstract][Full Text] [Related]
19. [Familial hypercholesterolemia: A largely underestimated cardiovascular risk]. Ferrières J; Bruckert É; Béliard S; Rabès JP; Farnier M; Krempf M; Cariou B; Danchin N Ann Cardiol Angeiol (Paris); 2018 Feb; 67(1):1-8. PubMed ID: 28576280 [TBL] [Abstract][Full Text] [Related]
20. Early diagnosis and treatment of familial hypercholesterolemia: improving patient outcomes. Alonso R; Mata P; Zambón D; Mata N; Fuentes-Jiménez F Expert Rev Cardiovasc Ther; 2013 Mar; 11(3):327-42. PubMed ID: 23469913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]